These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 3010079

  • 1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, Beavo JA.
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue.
    Degerman E, Manganiello VC, Newman AH, Rice KC, Belfrage P.
    Second Messengers Phosphoproteins; 1988 May; 12(4):171-82. PubMed ID: 2854560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
    Rascón A, Lindgren S, Stavenow L, Belfrage P, Andersson KE, Manganiello VC, Degerman E.
    Biochim Biophys Acta; 1992 Mar 16; 1134(2):149-56. PubMed ID: 1313303
    [Abstract] [Full Text] [Related]

  • 8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 16; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
    Whalin ME, Strada SJ, Thompson WJ.
    Biochim Biophys Acta; 1988 Oct 28; 972(1):79-94. PubMed ID: 2846074
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of amrinone and enoximone on the subclasses of cyclic AMP phosphodiesterase from human heart and kidney.
    Masuoka H, Ito M, Nakano T, Naka M, Tanaka T.
    J Cardiovasc Pharmacol; 1990 Feb 28; 15(2):302-7. PubMed ID: 1689427
    [Abstract] [Full Text] [Related]

  • 13. Two isoforms of cGMP-inhibited cyclic nucleotide phosphodiesterases in human tissues distinguished by their responses to vesnarinone, a new cardiotonic agent.
    Masuoka H, Ito M, Sugioka M, Kozeki H, Konishi T, Tanaka T, Nakano T.
    Biochem Biophys Res Commun; 1993 Jan 29; 190(2):412-7. PubMed ID: 8381275
    [Abstract] [Full Text] [Related]

  • 14. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF.
    J Mol Cell Cardiol; 1996 Oct 29; 28(10):2151-61. PubMed ID: 8930810
    [Abstract] [Full Text] [Related]

  • 15. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M, Yanagisawa T, Taira N, Blinks JR.
    Circulation; 1986 Mar 29; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [Abstract] [Full Text] [Related]

  • 16. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
    Macphee CH, Reifsnyder DH, Moore TA, Beavo JA.
    J Cyclic Nucleotide Protein Phosphor Res; 1986 Mar 29; 11(7):487-96. PubMed ID: 2831258
    [Abstract] [Full Text] [Related]

  • 17. Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.
    Silver PJ, Allen P, Etzler JH, Hamel LT, Bentley RG, Pagani ED.
    Second Messengers Phosphoproteins; 1990 Mar 29; 13(1):13-25. PubMed ID: 2286932
    [Abstract] [Full Text] [Related]

  • 18. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1998 May 29; 124(1):129-40. PubMed ID: 9630352
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Scholz H, Meyer W.
    Circulation; 1986 Mar 29; 73(3 Pt 2):III99-108. PubMed ID: 2417748
    [Abstract] [Full Text] [Related]

  • 20. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC, Kanter JR, Brunton LL.
    Circ Res; 1991 Apr 29; 68(4):1070-9. PubMed ID: 1849058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.